Regenity Redefines Medical Device Innovation Via Advanced Contract Development and Manufacturing Expertise, Honored with Prestigious 2025 R&D 100 Award

Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners portfolio company, today announced that it has been recognized as a winner of the 2025 R&D 100 Awards for its RejuvaKnee™ meniscal repair innovation.

RejuvaKnee™ is designed to encourage tissue regeneration and preserve meniscal function, offering patients a solution that maintains the natural biomechanics of the knee and redefines the standard for meniscal repair. As a next generation advancement in orthopedics, RejuvaKnee™ reflects Regenity’s mission to advance regenerative science and deliver solutions that drive healing forward- while also demonstrating the depth of its R&D and manufacturing expertise in bringing innovative technologies from concept to commercial reality.

“This award is a powerful validation of the speed, focus and rigor that defines Regenity,” said Shawn McCarthy, Chief Executive Officer of Regenity. “Our team moved with urgency to deliver this breakthrough, inspired by the patients who deserve more effective solutions for meniscal repair. This recognition highlights the transformative potential of RejuvaKnee™, but also Regenity’s ability to deliver innovation with the discipline and regulatory acumen that our partners and patients can trust.”

Regenity partners with the medtech industry through contract development and manufacturing services designed to help companies bring regenerative innovation to life with speed and precision. Leveraging more than 70,000 square feet of FDA-registered, ISO 13485-certified facilities in the United States and the Netherlands, Regenity serves as a trusted partner of choice, providing end-to-end support—from early product development and regulatory strategy to full-scale, GMP-compliant manufacturing—to help bring regenerative technologies to patients worldwide.

The 63rd R&D 100 Awards, widely regarded as the “Oscars of Innovation,” honor the 100 most impactful technologies introduced globally each year. Winners of the 2025 R&D 100 Awards were announced on August 21, 2025, and honorees will be celebrated at the R&D 100 Awards Gala in Scottsdale, Arizona on November 20, 2025.

Regenity will also be featured in the November issue of R&D World Magazine, a special edition highlighting the 2025 award winners.